Pacific Edge: FY20 Result — No Change in the Script
Pacific Edge FY20 Result — No Change in the Script RESEARCH INSIGHTS Pacific Edge's (PEB) FY20 result provided little in the way of new...
113 Views
Pacific Edge: A Game of Patience
Pacific Edge A Game of Patience RESEARCH INSIGHTS We lower our near-term revenue expectations for Pacific Edge (PEB) ahead of the upcoming FY20...
111 Views
Pacific Edge - CMS coverage pending
Pacific Edge continues to make progress commercialising its Cxbladder suite of bladder cancer diagnostics products, with three of the four...
1k Views
Pacific Edge: 1H20 Result and Capital Raise
Pacific Edge 1H20 Result and Capital Raise Pacific Edge (PEB) announced a fully underwritten NZ$20m capital raise alongside its 1H20 result, as it...
916 Views
Pacific Edge - Anticipating commercial growth
Pacific Edge continues to make progress commercialising its suite of bladder cancer diagnostics products, with three tests currently available in...
71 Views